Clinical Trials Directory

Trials / Unknown

UnknownNCT04116892

Comparative Analysis of Large Macular Hole Surgeries

Prospective, Consecutive, Non-randomized,Interventional Trial of Comparative Analysis of Large Macular Hole Surgeries

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study compares the anatomical and visual outcomes in a large series of patients affected by idiopathic macular holes larger than 400 µm treated using pars plana vitrectomy and gas tamponade combined with internal limiting membrane (ILM) peeling or the inverted internal limiting membrane flap technique. A part of the participants will receive internal limiting membrane peeling,whil the other will receive the inverted internal limiting membrane flap technique.

Detailed description

Vitrectomy is the standard treatment for idiopathic macular holes (IMHs) and is combined with removal of the internal limiting membrane (ILM) to improve anatomical outcomes.However, surgical closure is not achieved after a single operation in all cases, and patients with long-standing MHs or highly myopic eyes are challenging to treat.Various surgical strategies have been introduced to improve postoperative outcomes for these cases. Michalewska et al. have reported an inverted ILM flap technique for large MHs. The ILM around the MH was left to cover or fill the hole and showed a better anatomical closure rate and visual outcome than ILM peeling for large MHs. Nevertheless, the functional and anatomic outcomes of the ILM flap technique have not been investigated as extensively as the ILM peeling technique and have yet to be confirmed by research comparing the ILM flap technique with the conventional procedure.

Conditions

Interventions

TypeNameDescription
PROCEDUREthe Cover groupThe internal limiting membrane around the MH was left to cover the hole
PROCEDUREthe Fill groupThe internal limiting membrane around the MH was left to fill the hole
PROCEDUREthe peeling groupthe internal limiting membrane was discarded

Timeline

Start date
2019-05-01
Primary completion
2021-06-30
Completion
2021-09-30
First posted
2019-10-07
Last updated
2020-10-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04116892. Inclusion in this directory is not an endorsement.